Qualification for Fusion Biopsy

Fusion Prostate Biopsy – Precise Cancer Diagnosis Using Cutting-Edge Technology

Modern and precise fusion prostate biopsy is the gold standard in diagnosing prostate cancer. By combining magnetic resonance imaging (MRI) with real-time ultrasound (USG), the procedure allows for targeted sampling of suspicious areas, increasing the chances of early disease detection.

The procedure is performed for men with elevated PSA levels, abnormal digital rectal exam results, or suspicious MRI findings (scored as PI-RADS 3, 4, or 5). It involves:

• Precise identification of diseased lesions in MRI,

• Overlaying MRI images with ultrasound (image fusion) for accurate tissue sampling,

• Minimally invasive collection of samples (20-40 cores) under ultrasound guidance, under general anesthesia.

The entire procedure takes 30-60 minutes, and the patient can return to daily activities within 24-48 hours.

When Should You Consider Fusion Biopsy?

• Elevated PSA levels,
• Abnormal digital rectal exam findings,
• Suspicious MRI lesions (PI-RADS ≥3).

• Up to 2x higher sensitivity – detects 72% of cancers (compared to 38% in classic TRUS biopsy).
• Minimizes infection risk – performed through the perineal skin, not the rectum, reducing the risk of prostatitis or sepsis.
• Precise targeting – lesions invisible on ultrasound are accurately located thanks to prior MRI.

✔ Comprehensive diagnostics – we perform both prostate MRI and biopsy in one place, ensuring the highest quality.
✔ Experienced specialists – procedures are carried out by urologists with years of expertise.
✔ Pain-free and safe – we use general anesthesia and the advanced Medcom system for maximum patient comfort.
✔ Quick recovery – minimal invasiveness allows for a fast return to normal activities.